Du et al. [53] examined a panel of renal biomarkers in MM patients with CKD, MM with normal kidney function, and healthy volunteers, observing elevated NGAL levels in both serum and urine in the “MM-renal group”, as compared to the remaining two. This evidence concerns the gene LCN2 and Miyoshi myopathy.